Genenta Science S.p.A.
Close on Oct 19, 2026
About Genenta Science S.p.A.
Biological Products, (No Diagnostic Substances), SIC 2836
Genenta Science S.p.A. is a clinical-stage biotechnology company focused on developing cell and gene therapies for the treatment of solid tumors and other cancer indications. The company utilizes cell-based gene therapy platforms, including lentiviral vector-based technologies engineered to target the tumor microenvironment without inducing widespread systemic toxicity. Its clinical development pipeline includes therapeutic candidates designed to harness immune responses against difficult-to-treat malignancies, intended for patients suffering from specialized solid tumor cancers.
The company conducts its operations across Europe and the United States, advancing collaborative clinical and preclinical research agreements with academic and medical institutions such as the San Raffaele Hospital. Its corporate operations and administrative leadership are centered in Italy, with its principal executive offices located in Milan, Italy.
Summary of the business section of Genenta Science S.p.A.'s latest annual report, written by StockData.
Company profile
Company
- Legal name
- Genenta Science S.p.A.
- Headquarters
- Milan, L6
- Address
- Olgettina, No. 58 20132
- Phone
- 39-02-2643-6639
- Website
- genenta.com
- Employees
- 13, Dec 31, 2024
- Industry
- Biological Products, (No Diagnostic Substances)
- Incorporated in
- L6
- Auditor
- Dannible & McKee, LLP, Syracuse, New York
Stock & identifiers
- Ticker
- GNTA
- Exchange
- Nasdaq
- Shares outstanding
- 23M, Dec 31, 2025
- Filer category
- Non-accelerated filer<br>Emerging growth company
- SEC CIK
- 1838716
- CUSIP
- 36870W100
- ISIN
- US36870W1009
- LEI
- 815600E860D130824E49
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Pierluigi Paracchi | Chief Executive Officer, Director | 27,000 |
| Francesco Galimi | CMO& Head of Development, Director | 0 |
| Richard B. Slansky | Chief Financial Officer | 2,200 |
| Giacomoantonio Paracchi | Director | 0 |
| Armon Sharei | Director | 0 |
| Miguel Maria Mutti | Director | 0 |
Employees
Headcount reported in annual reports
“As of March 26, 2025, we had 13 full-time employees, 11 located in Milan, Italy, and two (2) located in the U.S.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Dec 1, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
| May 19, 2021 | Name change | Name changed from Genenta Science S.r.l. to Genenta Science S.p.A. |